77 studies found for:    agitation and alzheimer's
Show Display Options
Rank Status Study
1 Completed
Has Results
Citalopram for Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Agitation
Interventions: Drug: citalopram;   Drug: placebo
2 Completed The Occurrence of the ApoE4 Allele in Agitated In-Patients With Late-Onset Alzheimer's Disease
Conditions: Alzheimer's Disease;   Agitation
Intervention:
3 Recruiting A Study of Two Fixed-doses of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
4 Recruiting Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
Conditions: Agitation Associated With;   Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention: Drug: Brexpiprazole, OPC-34712
5 Completed Treatment for Aggression and Agitation in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: LY451395;   Drug: Placebo
6 Recruiting Treatment of Psychosis and Agitation in Alzheimer's Disease
Conditions: Alzheimer's Disease;   Psychosis;   Agitation
Interventions: Drug: Lithium;   Drug: Placebo
7 Not yet recruiting Efficacy, Safety and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type
Intervention: Drug: AVP-786
8 Not yet recruiting Efficacy, Safety, and Tolerability of AVP-786 (Deuterated [d6]-Dextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type
Condition: Agitation in Patients With Dementia of the Alzheimer's Type
Intervention: Drug: AVP-786
9 Completed An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: memantine HCl
10 Recruiting Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ORM-12741;   Drug: Placebo
11 Completed Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
12 Enrolling by invitation Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo
Conditions: Agitation Associated With Alzheimer's Disease;   Alzheimer's Type;   Mental Disorder;   Nervous System Diseases
Intervention:
13 Completed Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ELND005;   Drug: Placebo
14 Completed
Has Results
Alzheimer's in Long-Term Care--Treatment for Agitation
Conditions: Alzheimer Disease;   Psychomotor Agitation
Interventions: Drug: prazosin;   Drug: placebo (inert substance)
15 Unknown  Memantine on Aggression and Agitation of Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Intervention: Drug: Memantine
16 Recruiting Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
Condition: Agitation Associated With Dementia of the Alzheimer's Type
Interventions: Drug: 2 mg/day;   Drug: 3 mg/day;   Drug: 6 mg/day;   Drug: Placebo (0 mg/day)
17 Completed Memantine for Agitation and Aggression in Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: memantine
18 Completed
Has Results
Valproate in Dementia (VALID)
Condition: Alzheimer Disease
Interventions: Drug: Valproate;   Drug: Placebo
19 Terminated A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Group 1 ELND005;   Drug: Group 2 ELND005
20 Completed Escitalopram Treatment of Patients With Agitated Dementia
Conditions: Alzheimer's Disease;   Psychomotor Agitation
Intervention: Drug: Escitalopram (Lexapro)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years